tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

GeneDx price target raised to $115 from $88 at Guggenheim

Guggenheim analyst Subbu Nambi raised the firm’s price target on GeneDx (WGS) to $115 from $88 and keeps a Buy rating on the shares. The price target increase reflects the tailwind and upside associated with the American Academy of Pediatrics guideline update, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1